rats
Recently, it was reported that blood vessel immunoreactive endothelin-1 (irET-1)        content is increased in hypertensive uremic rats treated with recombinant human       erythropoietin (rhEPO).
Recently, it was reported that blood vessel immunoreactive  @OBJECT$  (irET-1)        content is increased  @PREDICAT$  hypertensive uremic  @SUBJECT$  treated with recombinant human       erythropoietin (rhEPO).